1
|
American Cancer Society: Cancer Facts and
Figures 2012. http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012.
|
2
|
Billoski TV: Introduction to Paleontology
2. Institutional Press; New York: 1992
|
3
|
Morris SR and Carey LA: Molecular
profiling in breast cancer. Rev Endocr Metab Disord. 8:185–198.
2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hartmann A, Blaszyk H, Saitoh S, Tsushima
K, Tamura Y, Cunningham JM, McGovern RM, Schroeder JJ, Sommer SS
and Kovach JS: High frequency of p53 gene mutations in primary
breast cancers in Japanese women, a low-incidence population. Br J
Cancer. 73:896–901. 1996. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hartmann A, Rosanelli G, Blaszyk H,
Cunningham JM, McGovern RM, Schroeder JJ, Schaid DJ, Kovach JS and
Sommer SS: Novel pattern of P53 mutation in breast cancers from
Austrian women. J Clin Invest. 95:686–689. 1995. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sorlie T, Tibshirani R, Parker J, Hastie
T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et
al: Repeated observation of breast tumor subtypes in independent
gene expression data sets. Proc Natl Acad Sci USA. 100:8418–8423.
2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hedenfalk I, Duggan D, Chen Y, Radmacher
M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M,
Kallioniemi OP, et al: gene-expression profiles in hereditary
breast cancer. N Engl J Med. 344:539–548. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chang JC, Wooten EC, Tsimelzon A,
Hilsenbeck Sg, Gutierrez MC, Elledge R, Mohsin S, Osborne CK,
Chamness GC, Allred DC, et al: Gene expression profiling for the
prediction of therapeutic response to docetaxel in patients with
breast cancer. Lancet. 362:362–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lehmann BD, Bauer JA, Chen X, Sanders ME,
Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human
triple-negative breast cancer subtypes and preclinical models for
selection of targeted therapies. J Clin Invest. 121:2750–2767.
2011. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Sabatier R, Finetti P, Adelaide J, Guille
A, Borg JP, Chaffanet M, Lane L, Birnbaum D and Bertucci F:
Down-regulation of ECRG4, a candidate tumor suppressor gene, in
human breast cancer. PLoS One. 6:e276562011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S,
Rostom A and Stuart RK: Locally advanced breast cancer in Saudi
Arabia: High frequency of stage III in a young population. Med
Oncol. 16:95–103. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lai FM, Chen P, Ku HC, Lee MS, Chang SC,
Chang TM and Liou SH: A case-control study of parity, age at first
full-term pregnancy, breast feeding and breast cancer in Taiwanese
women. Proc Natl Sci Counc Repub China B. 20:71–77. 1996.PubMed/NCBI
|
13
|
Renehan AG, Soerjomataram I and Leitzmann
MF: Interpreting the epidemiological evidence linking obesity and
cancer: A framework for population-attributable risk estimations in
Europe. Eur J Cancer. 46:2581–2592. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Surmacz E: Obesity hormone leptin: A new
target in breast cancer? Breast Cancer Res. 9:3012007.PubMed/NCBI
|
16
|
Jensen LJ, Kuhn M, Stark M, Chaffron S,
Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et
al: STRING 8 - a global view on proteins and their functional
interactions in 630 organisms. Nucleic Acids Res. 37:D412–D416.
2009. View Article : Google Scholar
|
17
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering
C, et al: STRING v9.1: Protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar :
|
18
|
Merdad A, Karim S, Schulten HJ, Jayapal M,
Dallol A, Buhmeida A, Al-Thubaity F, GariI MA, Chaudhary AG,
Abuzenadah AM, et al: Transcriptomics profiling study of breast
cancer from Kingdom of Saudi Arabia revealed altered expression of
Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism
associated with breast cancer? BMC Genomics. 16(Suppl 1): S112015.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Merdad A, Karim S, Schulten HJ, Dallol A,
Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM and
Al-Qahtani MH: Expression of matrix metalloproteinases (MMPs) in
primary human breast cancer: MMP-9 as a potential biomarker for
cancer invasion and metastasis. Anticancer Res. 34:1355–1366.
2014.PubMed/NCBI
|
20
|
Al-Othaimeen AI, Al-Nozha M and Osman AK:
Obesity: An emerging problem in Saudi Arabia. Analysis of data from
the National Nutrition Survey. East Mediterr Health. 13:441–448.
2007.
|
21
|
White KK, Park SY, Kolonel LN, Henderson
BE and Wilkens LR: Body size and breast cancer risk: The
Multiethnic Cohort. Int J Cancer. 131:E705–E716. 2012. View Article : Google Scholar
|
22
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Blüher S and Mantzoros CS: Leptin in
humans: Lessons from translational research. Am J Clin Nutr.
89:991S–997S. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Janeckova R: The role of Leptin in human
physiology and pathophysiology. Physiol Res. 50:443–459.
2001.PubMed/NCBI
|
25
|
Körner A, Pazaitou-Panayiotou K, Kelesidis
T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A,
Tseleni S, Mitsiades N, et al: Total and high-molecular-weight
adiponectin in breast cancer: In vitro and in vivo studies. J Clin
Endocrinol Metab. 92:1041–1048. 2007. View Article : Google Scholar
|
26
|
Hammamieh R, Chakraborty N, Barmada M, Das
R and Jett M: Expression patterns of fatty acid binding proteins in
breast cancer cells. J Exp Ther Oncol. 5:133–143. 2005.
|
27
|
Boneberg EM, Legler DF, Hoefer MM,
Ohlschlegel C, Steininger H, Füzesi L, Beer GM, Dupont-Lampert V,
Otto F, Senn HJ, et al: Angiogenesis and lymphangiogenesis are
downregulated in primary breast cancer. Br J Cancer. 101:605–614.
2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Pauwels EK and Kairemo K: Fatty acid
facts, part II: Role in the prevention of carcinogenesis, or, more
fish on the dish? Drug News Perspect. 21:504–510. 2008. View Article : Google Scholar
|
29
|
Escrich E, Solanas M, Moral R and Escrich
R: Modulatory effects and molecular mechanisms of olive oil and
other dietary lipids in breast cancer. Curr Pharm Des. 17:813–830.
2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Moschos S, Chan JL and Mantzoros CS:
Leptin and reproduction: A review. Fertil Steril. 77:433–444. 2002.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Considine RV, Sinha MK, Heiman ML,
Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee
LJ, Bauer TL, et al: Serum immunoreactive-leptin concentrations in
normal-weight and obese humans. N Engl J Med. 334:292–295. 1996.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Jardé T, Perrier S, Vasson MP and
Caldefie-Chézet F: Molecular mechanisms of leptin and adiponectin
in breast cancer. Eur J Cancer. 47:33–43. 2011. View Article : Google Scholar
|
33
|
Tessitore L, Vizio B, Jenkins O, De
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI
|
34
|
Saxena NK, Taliaferro-Smith L, Knight BB,
Merlin D, Anania FA, O'Regan RM and Sharma D: Bidirectional
crosstalk between leptin and insulin-like growth factor-I signaling
promotes invasion and migration of breast cancer cells via
transactivation of epidermal growth factor receptor. Cancer Res.
68:9712–9722. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo
FC, Fu OY, Chen HY, Hou MF and Yuan SS: Serum adiponectin and
leptin levels in Taiwanese breast cancer patients. Cancer Lett.
237:109–114. 2006. View Article : Google Scholar
|
36
|
Russell CD, Petersen RN, Rao SP, Ricci MR,
Prasad A, Zhang Y, Brolin RE and Fried SK: Leptin expression in
adipose tissue from obese humans: Depot-specific regulation by
insulin and dexamethasone. Am J Physiol. 275:E507–E515.
1998.PubMed/NCBI
|
37
|
Wang J, Liu R, Hawkins M, Barzilai N and
Rossetti L: A nutrient-sensing pathway regulates leptin gene
expression in muscle and fat. Nature. 393:684–688. 1998. View Article : Google Scholar : PubMed/NCBI
|
38
|
Rosmond R, Dallman MF and Björntorp P:
Stress-related cortisol secretion in men: Relationships with
abdominal obesity and endocrine, metabolic and hemodynamic
abnormalities. J Clin Endocrinol Metab. 83:1853–1859.
1998.PubMed/NCBI
|
39
|
Gong DW, Bi S, Pratley RE and Weintraub
BD: genomic structure and promoter analysis of the human obese
gene. J Biol Chem. 271:3971–3974. 1996. View Article : Google Scholar : PubMed/NCBI
|
40
|
Li H, Matheny M and Scarpace PJ: beta
3-Adrenergic-mediated suppression of leptin gene expression in
rats. Am J Physiol. 272:E1031–E1036. 1997.PubMed/NCBI
|
41
|
Fried SK, Ricci MR, Russell CD and
Laferrère B: Regulation of leptin production in humans. J Nutr.
130:3127S–3131S. 2000.
|